Christopher J Morabito
Chief Tech/Sci/R&D Officer at ASTRIA THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Christopher J Morabito active positions
Companies | Position | Start | End |
---|---|---|---|
ASTRIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-07-14 | - |
Career history of Christopher J Morabito
Former positions of Christopher J Morabito
Companies | Position | Start | End |
---|---|---|---|
FULCRUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-05-09 | 2022-07-12 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Tech/Sci/R&D Officer | 2016-09-30 | 2020-06-30 |
MERCK & CO., INC. | Director/Board Member | 2010-09-30 | 2014-03-31 |
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Christopher J Morabito
Franklin & Marshall College | Undergraduate Degree |
Penn State Hershey College of Medicine | Doctorate Degree |
Statistics
International
United States | 7 |
Japan | 2 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
ASTRIA THERAPEUTICS, INC. | Health Technology |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Health Technology |